Patents Assigned to HLA-G TECHNOLOGIES
  • Publication number: 20120177671
    Abstract: The present invention relates to alpha 1 multimers and the uses thereof. The invention also relates to methods of producing such multimers, pharmaceutical compositions comprising the same, as well as their uses for treating various diseases including organ/tissue rejection.
    Type: Application
    Filed: June 16, 2010
    Publication date: July 12, 2012
    Applicant: HLA-G TECHNOLOGIES
    Inventors: Laurence Rulleau, Jacques-Francois Martin
  • Publication number: 20110274711
    Abstract: The present invention relates to novel proteins and pharmaceutical uses thereof The invention more specifically relates to novel proteins comprising the sequence of an HLA-5 antigen fused to the sequence of a b2 microglobulin. The invention also relates to methods of producing such polypeptides, pharmaceutical compositions comprising the same, as well as their uses for treating various diseases including organ/tissue rejection.
    Type: Application
    Filed: November 4, 2009
    Publication date: November 10, 2011
    Applicants: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, HLA-G TECHNOLOGIES
    Inventors: Benoit Favier, Edgardo D. Carosella, Joël Lemaoult
  • Publication number: 20110268737
    Abstract: The present invention relates to novel proteins and pharmaceutical uses thereof. The invention more specifically relates to novel fusion proteins comprising a domain of an HLA-G antigen fused to an Fc domain of an immunoglobulin. The invention also relates to methods of producing such polypeptides, pharmaceutical compositions comprising the same, as well as their uses for treating various diseases including organ/tissue rejection.
    Type: Application
    Filed: November 4, 2009
    Publication date: November 3, 2011
    Applicants: COMMISSARIAT A L'ENEGRIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, HLA-G TECHNOLOGIES
    Inventors: Benoit Favier, Edgardo D. Carosella, Joël Lemaoult